Collegium Pharmaceutical Inc (COLL)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	377,344	373,686	357,203	340,223	326,169	281,328	259,856	238,394	209,488	158,366	145,640	143,515	150,617	196,242	198,322	196,447	179,836	160,659	138,654	116,676
Revenue (ttm)	US$ in thousands	631,449	599,245	576,653	566,923	566,767	546,642	536,946	524,949	463,933	361,675	313,505	272,898	276,868	325,777	326,110	321,226	310,016	307,948	301,714	298,696
Gross profit margin		59.76%	62.36%	61.94%	60.01%	57.55%	51.46%	48.40%	45.41%	45.15%	43.79%	46.46%	52.59%	54.40%	60.24%	60.81%	61.16%	58.01%	52.17%	45.96%	39.06%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $377,344K ÷ $631,449K
= 59.76%

Collegium Pharmaceutical Inc has shown fluctuating gross profit margin percentages over the past few years. The trend indicates an improvement in profitability from March 2020 to June 2021, with the margin increasing steadily from 39.06% to 60.81%. However, from September 2021 to December 2024, there was some volatility in the gross profit margin, ranging from 43.79% to 62.36%.

The highest gross profit margin was recorded at 62.36% on September 30, 2024, while the lowest was at 39.06% on March 31, 2020. Overall, Collegium Pharmaceutical Inc has experienced periods of strong profitability but also some fluctuations in gross profit margin. It is important for the company to continue monitoring and managing its costs effectively to maintain a healthy gross profit margin and sustainable profitability.